Previous 10 | Next 10 |
2024-03-23 05:50:46 ET Summary Eli Lilly's stock price has increased by 129% in a year, with a Forward Price-To-Earnings Ratio of 60.4. Lilly's valuation in a base case scenario at $171/share, considering traditional drug revenues. New growth markets, such as obesity, Alzheime...
2024-03-22 09:41:41 ET Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns Pfizer Inc. (PFE) Leerink Partners Global Biopharma Conference 2024 - (Transcript) Pfizer: Seagen Acquisition Starting To Bear Fruit Pfizer gets EU backing fo...
2024-03-22 07:15:00 ET The pharmaceutical industry is scrambling for breakthroughs in weight loss treatment. Demand for medications such as Ozempic, Wegovy, Mounjaro, and Zepbound is rising. All of these diabetes and obesity treatments are developed by just two companies: Novo Nordisk ...
2024-03-22 04:55:00 ET Eli Lilly (NYSE: LLY) has become a giant in what may be a $100 billion market a few years from now. I'm talking about the world of weight loss drugs. Doctors have been prescribing Mounjaro and the newly approved Zepbound to patients aiming to shed pounds, ...
2024-03-21 13:57:00 ET Summary DoorDash and Wing have partnered to launch drone delivery of Wendy's menu items in the U.S. Wall Street declares Micron the next AI beneficiary after strong results. Check out Jefferies' stock picks in the Russell index with most buying support a...
2024-03-21 13:35:23 ET More on Eli Lilly, Novo Nordisk, etc. Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Eli Lilly and Co (LLY) Cowen's 44th Annual Health Care Confer...
2024-03-21 11:53:17 ET More on S&P 500 Index: Chairman Powell Hits A Grand Slam Home Run Despite What The Fed Says, The Policy Is Still 'Higher-For-Longer' The Fed Is More Dovish Than The Market Anticipates 32 “Breakthroughs” stocks by BofA ...
2024-03-20 13:09:31 ET More on Eli Lilly, Novo Nordisk, etc. Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Eli Lilly and Co (LLY) Cowen's 44th Annual Health Care Confer...
2024-03-20 11:40:23 ET More on iShares Russell 1000 Growth ETF, iShares Russell 2000 ETF, etc. IWF ETF: Solid Track Record, But Looks Overextended Now IWM: Are Small Caps Being Overlooked In The Megacap Market Frenzy? IWM: Super Micro Computer Is Leading The Russell ...
2024-03-20 09:00:32 ET More on Labcorp Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Call Transcript Laboratory Corporation of America Holdings 2023 Q4 - Results - Earnings Call Presentation Labcorp introduces weight loss management portfolio ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...